Repligen
Open
$131.26
Prev. Close
$131.19
High
$131.36
Low
$130.46
Market Snapshot
$7.36B
143.1
-0.46
$634.44M
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
RBC Capital resumed coverage of Repligen following Q1 2026 results that surpassed expectations, highlighting the company’s strong performance in the bioprocessing sector.
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Recently from Cashu
Repligen Opens New Training & Innovation Center in Breda, Netherlands for Bioprocessing Strategy.
Repligen Corporation enhances its commitment to bioprocessing innovation with the opening of its new Training & Innovation Center at the OPUS pre-packed chromatography column manufacturing site in Bre…
Repligen's Approach to Bioprocessing: Innovation Amidst Analyst Mixed Perspectives
Repligen Corporation: Navigating the Future of Bioprocessing Solutions Repligen Corporation stands at a pivotal juncture in the evolving biopharmaceutical landscape, highlighted by recent analyst rati…
Repligen's Innovations Shine Amid Mixed Analyst Opinions on Growth Potential
Repligen's Steady Ascent Amid Mixed Analyst Sentiment Repligen Corporation is a key player in the bioprocessing solutions sector, and the company's innovative technologies continue to draw attention a…
Repligen Analysts Assess Strategic Positioning Amid Biopharmaceutical Growth Opportunities and Challenges
### Repligen's Strategic Positioning in Bioprocessing: Analyst Insights Repligen Corporation, a leader in bioprocessing technologies, currently attracts attention from market analysts as it continues…